MDxHealth, Inc. Provides First Quarter 2012 Business Update
5/16/2012 10:51:41 AM
IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today issued its business update for the quarter ended March 31, 2012.
comments powered by